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Metabolic syndrome (MetS) is the name given to a cluster of conditions that occur together more often than can be explained by
chance. It is estimated that 20–25 % of the global adult population have MetS(1) and are three times as likely to suffer a heart attack
or stroke and have a ﬁvefold greater risk of developing type-2 diabetes compared with people who do not have MetS(2–3).
The PATHWAY-27 project evaluated the effectiveness of bioactive enriched food (BEF) on improving risk factors of MetS in par-
ticipants at risk, or with, MetS. Following ethical approval, the trial was registered on clinicaltrials.gov (trial # NCT02702713). The
bioactive compounds selected were docosahexaenoic acid (DHA), oat beta-glucan (OBG) and grape anthocyanins (AC). In a multi-
centre, randomized, double-blind, nutritional intervention trial, 251 human volunteers were recruited to consume BEF for 12 weeks.
Metabolic and anthropometric markers were measured at 0, 6 and 12 weeks. Dietary exposure to DHA, OBG and AC from the par-
ticipants’ typical diet was assessed at baseline using a food frequency questionnaire. Participants were asked to estimate the frequency
of consumption and portion size of foods known to contain each bioactive over 6-weeks prior to the start of the trial. Bioactive com-
position information was derived from national and international databases (EuroFIR; Polyphenol Explorer), literature information
and direct analysis of foods. A deterministic exposure analysis was used to calculate dietary exposure for each participant enrolled
in the trial according to equation (1) where E = exposure of individual (j); n = number of portions on day (k) of food commodity
(l), w = portion of food, c = concentration of bioactive.
The results (table 1) indicated generally low intakes of DHA, OBG and AC (evidenced by low mean) with great individual vari-
ation, and were associated with generally low consumption of ﬁsh, wholegrain oat, fruits, vegetables and legumes. Poor diet may con-
tribute to the participants MetS phenotype and justiﬁes interventions to increase bioactive intake. Bioactive exposure will be validated
with metabolomics analysis of urine and serum.
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Table 1. Bioactive dietary exposure at baseline of participants of the Pathway-27 trial (n = 281).
Bioactive exposure (mg/day)
Mean Std. Dev. Std. Error Min Max
DHA 92·46 205·60 12·98 0·00 1659·00
OBG 246·28 557·63 35·48 0·00 3330·60
AC 79·23 101·75 7·46 0·00 685·70
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